Recruitment of dendritic cells and enhanced antigen-specific immune reactivity in cancer patients treated with hr-GM-CSF (Molgramostim) and hr-IL-2 - results from a phase Ib clinical trial

Author: Correale P.   Campoccia G.   Tsang K.Y.   Micheli L.   Cusi M.G.   Sabatino M.   Bruni G.   Sestini S.   Petrioli R.   Pozzessere D.   Marsili S.   Fanetti G.   Giorgi G.   Francini G.  

Publisher: Elsevier

ISSN: 0959-8049

Source: European Journal of Cancer, Vol.37, Iss.7, 2001-05, pp. : 892-902

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content